Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Drorit Merkel"'
Autor:
Itay Barnea, Lior Luria, Arik Girsault, Ofira Dabah, Matan Dudaie, Simcha K. Mirsky, Drorit Merkel, Natan T. Shaked
Publikováno v:
Bioengineering, Vol 11, Iss 3, p 256 (2024)
Myelodysplastic syndromes (MDSs) are a group of potentially deadly diseases that affect the morphology and function of neutrophils. Rapid diagnosis of MDS is crucial for the initiation of treatment that can vastly improve disease outcome. In this wor
Externí odkaz:
https://doaj.org/article/711506e9e5464c88a822e9ae6821f19f
Autor:
Galia Rahav, Yaniv Lustig, Jacob Lavee, Ohad Benjamini, Hila Magen, Tammy Hod, Noga Shem-Tov, Einat Shacham Shmueli, Drorit Merkel, Ziv Ben-Ari, Rebecca Halperin, Victoria Indenbaum, Liraz Olmer, Amit Huppert, Eytan Mor, Gili Regev-Yochay, Carmit Cohen, Anat Wieder- Finesod, Itzchak Levy
Publikováno v:
EClinicalMedicine, Vol 41, Iss , Pp 101158- (2021)
Background: Trials of the Pfizer-BioNTech BNT162b2 mRNA vaccine showed 95% efficacy in preventing symptomatic disease; however, the trials excluded immunocompromised patients (ICPs). We aim at analyzing antibody response in ICPs. Methods: A prospecti
Externí odkaz:
https://doaj.org/article/2a3831c73df74c8a915b4e700d2307d7
Autor:
Hussam Ghoti, Eitan Fibach, Drorit Merkel, Galit Perez-Avraham, Sigal Grisariu, Eliezer A Rachmilewitz
Publikováno v:
Haematologica, Vol 95, Iss 8 (2010)
Externí odkaz:
https://doaj.org/article/c98b2ff8fb604110a6fd8ea06879355d
Autor:
Rahav, Galia, Lustig, Yaniv, Lavee, Jacob, Ohad Benjamini, Magen, Hila, Hod, Tammy, Noga Shem-Tov, Shmueli, Einat Shacham, Drorit Merkel, Ben-Ari, Ziv, Halperin, Rebecca, Indenbaum, Victoria, Olmer, Liraz, Huppert, Amit, Mor, Eytan, Regev-Yochay, Gili, Cohen, Carmit, Finesod, Anat Wieder, Levy, Itzchak
Publikováno v:
In eClinicalMedicine November 2021 41
Autor:
Amit Huppert, Anat Wieder Finesod, Eytan Mor, Galia Rahav, Victoria Indenbaum, Tammy Hod, Gili Regev-Yochay, Ohad Benjamini, Carmit Cohen, Noga Shem-Tov, Rebecca Halperin, Drorit Merkel, Yaniv Lustig, Liraz Olmer, Jacob Lavee, Hila Magen, Einat Shmueli, Ziv Ben-Ari, Itzchak Levy
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 41, Iss, Pp 101158-(2021)
EClinicalMedicine, Vol 41, Iss, Pp 101158-(2021)
Background Trials of the Pfizer-BioNTech BNT162b2 mRNA vaccine showed 95% efficacy in preventing symptomatic disease; however, the trials excluded immunocompromised patients (ICPs). We aim at analyzing antibody response in ICPs. Methods A prospective
Autor:
Arnon Nagler, Jonathan Canaani, Gal Sharvit, Abraham Avigdor, Gabriel Heering, Maya Zlotnik, Avichai Shimoni, Drorit Merkel
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(2)
Achievement of initial remission remains the most important clinical factor predicting long term survival in acute myeloid leukemia (AML) patients treated with intensive chemotherapy. Yet, whether the patient subset in need of a second cycle of inten
Autor:
Ninette Amariglio, Iliya Novikov, Luba Trakhtenbrot, Drorit Merkel, Shelly Soffer, Arnon Nagler, Abraham Avigdor
Publikováno v:
Leukemia & Lymphoma. 60:764-771
Chromosome banding analysis (CBA) in myelodysplastic syndromes (MDS) remains the 'gold standard' for identification of chromosomal abnormalities, while interphase fluorescence in-situ hybridization (I-FISH) is mainly used to complement CBA. This stud
Autor:
Drorit Merkel, Roni Shouval, Ilan Goldenberg, Shaye Kivity, Ilan Ben-Zvi, Sharon Katz, Yechezkel Sidi, Arnon Nagler, Elad Maor, Shlomo Segev
Publikováno v:
European Journal of Haematology. 98:435-442
Background Data on the functional impact of anemia on cardiorespiratory fitness (CRF) and survival in healthy individuals are limited. Our aim was to evaluate the association between anemia thresholds, low CRF, and survival in otherwise healthy adult
Autor:
Moshe E. Gatt, Arnon Nagler, Drorit Merkel, Yishai Ofran, Ilana Helman, Ron Ram, Tsofia Inbar, Irit Avivi
Publikováno v:
Annals of Hematology. 96:575-579
Elderly and infirm patients with acute myeloid leukemia (AML) with either induction refractory or relapse disease may benefit from treatment with azacitidine. We retrospectively reviewed the data from five tertiary centers in Israel, treated between
Autor:
Avichai Shimoni, David Lavie, Arnon Nagler, Ohad Benjamini, Ronit Yerushalmi, Elad Jacobi, Michal J. Besser, Abraham Avigdor, Riva Fineman, Ivetta Danylesko, Noga Shem-Tov, Tamar Tadmor, Drorit Merkel
Publikováno v:
Blood. 136:40-40
Background: Richter's transformation (RT) is a rare complication of Chronic Lymphocytic Leukemia (CLL), usually into clonally related diffuse large B cell lymphoma (DLBCL). Currently there is no effective therapy to RT and CLL relapse after targeted